Nifty Pharma Today: Index Performance, Stocks, Gainers & Losers

Updated: 19 Aug 2026 • 4:44 pm

Posted by:

Nifty Pharma Today: Index Performance, Stocks, Gainers & Losers

Nifty Pharma today closed on a mildly negative note, but the headline move alone does not fully capture how the sector behaved through the session. The index ended at 26,313.8, down 48.1 points or 0.18% from the previous close of 26,361.9. While the fall looks limited at the index level, the broader picture inside the basket was distinctly weak: only 4 of 20 stocks advanced, while 16 stocks declined. That means the pharma pack saw broad-based pressure even though a few stronger names helped limit the final damage.

For investors tracking sector rotation, defensive themes, and stock-specific action within Indian healthcare and pharmaceuticals, today’s session offered an important signal. Nifty Pharma remained relatively stable on the surface, but the market breadth was clearly negative. In simple terms, this was not a day when weakness was concentrated in just one or two stocks. Instead, most constituents closed in the red, suggesting selective buying in leaders and broader profit-taking across the rest of the pack.

This article breaks down Nifty Pharma live performance using the verified end-of-day snapshot, constituent moves, market breadth, top gainers, top losers, and the role of heavyweight names. It is designed for users searching for Nifty Pharma today, Nifty Pharma performance, Nifty Pharma stocks, Nifty Pharma gainers, and Nifty Pharma losers.

Table of Contents

Nifty Pharma Today Snapshot

Metric	Value
Current Value	26,313.8
Absolute Change	-48.1
Percentage Change	-0.18%
Opening Value	26,337.9
Previous Close	26,361.9
Day High	26,434.35
Day Low	26,205.4
Market Status	Closed
Last Updated	19 August 2026 at 4:00:00 PM IST
Market Trend	Sideways to bearish

Nifty Pharma opened at 26,337.9, slightly below the previous close, and traded in a relatively contained intraday range. The index touched a high of 26,434.35 and a low of 26,205.4 before ending near the middle-lower part of the day’s range. That kind of price structure usually reflects a session where buyers were present in pockets, but not strong enough to reverse broad selling pressure across the sector.

The final decline of 0.18% may look modest, yet the breadth tells a more cautious story. Strong gains in select stocks such as Sun Pharmaceutical Industries, Ipca Laboratories, Torrent Pharmaceuticals, and Mankind Pharma helped cushion the index. However, deeper cuts in several other names, especially JB Chemicals & Pharmaceuticals and Glenmark Pharmaceuticals, pulled the overall sector lower.

How Nifty Pharma Moved During the Session

From the day’s opening level of 26,337.9, Nifty Pharma initially attempted to push higher and reached 26,434.35. That move showed that the sector did not face one-way selling from the start. However, the inability to hold above the day’s high and the later drift toward 26,205.4 suggested that selling pressure built up as the session progressed.

Even though the index did not collapse, the internal structure of the move was softer than the benchmark reading implies. A market can remain almost flat or only slightly negative while still reflecting notable weakness under the surface, and that is exactly what happened here. With 80% of constituents closing in the red, today’s Nifty Pharma action was more fragile than the index percentage change alone suggests.

For short-term traders and sector watchers, this distinction matters. A narrow fall with broad declines can indicate that larger or relatively resilient names absorbed some of the pressure, while a majority of stocks failed to participate on the upside. That can be an early sign of stock-specific divergence inside the sector.

Why Nifty Pharma Was Under Pressure Today

Based on the verified price and breadth data, Nifty Pharma’s decline today appears to have been driven primarily by broad-based constituent weakness rather than by a collapse in one single heavyweight. The sector had only four advancing stocks, while sixteen declined. This kind of distribution generally points to a softer undertone across the pharma basket.

The strongest positive support came from Sun Pharmaceutical Industries Ltd., which rose 1.33%, and Ipca Laboratories Ltd., which gained 1.15%. Torrent Pharmaceuticals Ltd. also added 0.84%, while Mankind Pharma Ltd. advanced 0.59%. These stocks prevented a steeper fall in the index.

On the other side, losses were sharper in several names. JB Chemicals & Pharmaceuticals Ltd. dropped 3.87%, the steepest fall in the index today. Glenmark Pharmaceuticals Ltd. fell 2.54%, while Alkem Laboratories Ltd. declined 1.69%. Aurobindo Pharma, Natco Pharma, Granules India, Biocon, and Zydus Lifesciences also ended lower.

Since the available verified dataset does not include corporate events, earnings triggers, policy announcements, or institutional flow figures, the cleanest conclusion is this: today’s move in Nifty Pharma was a breadth-led decline, moderated by gains in a few leading and active stocks. That makes the session useful for identifying internal strength and weakness within the index, even without assigning unsupported external causes.

Market Breadth: What the Internal Data Says

Breadth Metric	Value
Advancing Stocks	4
Declining Stocks	16
Unchanged Stocks	0
Advance-Decline Ratio	0.25
Stocks in Green	20%
Stocks in Red	80%

Market breadth is one of the most important tools for understanding whether an index move is broad and healthy or narrow and fragile. In Nifty Pharma today, the breadth was clearly weak. Only 4 out of 20 stocks closed in the green, while 16 closed in the red. The advance-decline ratio stood at 0.25, which means there was only one advancing stock for every four declining stocks.

This is an important takeaway because a sector index can sometimes hide internal weakness if one or two larger names perform well. That seems to be the case today. Gains in Sun Pharma and a few other outperformers kept the index decline limited, but the broad list of decliners shows that the average pharma stock had a much weaker session than the benchmark suggests.

For investors, weak breadth with only a small index decline can mean two things. First, leadership within the sector may be narrowing. Second, stock selection becomes more important than simply taking a broad sector view. In such environments, stronger names tend to stand out more clearly, while weaker names can see deeper downside even if the overall index stays relatively stable.

Complete Nifty Pharma Constituent Performance

Company	CMP	Today's %	Today's Change	Day Open	Day High	Day Low	Trend
JB Chemicals & Pharmaceuticals Ltd.	2,408.9	-3.87%	-97.1	2,506	2,525.5	2,380	Bearish
Glenmark Pharmaceuticals Ltd.	2,246.5	-2.54%	-58.5	2,301	2,313.9	2,222.5	Bearish
Alkem Laboratories Ltd.	5,382.5	-1.69%	-92.5	5,475	5,489.5	5,370	Bearish
Sun Pharmaceutical Industries Ltd.	1,900	1.33%	24.9	1,871	1,900	1,871	Bullish
Natco Pharma Ltd.	886.85	-1.28%	-11.5	898.95	916	883	Bearish
Aurobindo Pharma Ltd.	1,624.5	-1.25%	-20.5	1,645	1,645	1,611.7	Bearish
Granules India Ltd.	841.15	-1.18%	-10.05	853.45	860.4	827.6	Bearish
Ipca Laboratories Ltd.	1,903.7	1.15%	21.6	1,882.1	1,937.9	1,863	Bullish
Biocon Ltd.	412.75	-1.14%	-4.75	416.55	417.75	411	Bearish
Zydus Lifesciences Ltd.	1,104.5	-0.99%	-11.1	1,115.6	1,127.7	1,104.5	Bearish
Torrent Pharmaceuticals Ltd.	5,013	0.84%	42	4,979.5	5,032.5	4,945.5	Bullish
Dr. Reddy's Laboratories Ltd.	1,170	-0.75%	-8.8	1,171.9	1,187.2	1,168	Bearish
Laurus Labs Ltd.	1,801.8	-0.67%	-12.2	1,814	1,818	1,789.9	Bearish
Abbott India Ltd.	26,405	-0.66%	-175	26,580	26,605	26,300	Bearish
Cipla Ltd.	1,422	-0.64%	-9.1	1,429	1,435.1	1,415.4	Bearish
Gland Pharma Ltd.	2,841.3	-0.61%	-17.3	2,852.9	2,881.4	2,827.5	Bearish
Mankind Pharma Ltd.	2,394	0.59%	14	2,380	2,423	2,380	Bullish
Divi's Laboratories Ltd.	8,560	-0.33%	-28	8,600	8,600	8,508	Bearish
Lupin Ltd.	2,225	-0.31%	-7	2,230	2,230	2,202.5	Bearish
Ajanta Pharma Ltd.	3,697.9	-0.23%	-8.5	3,706.4	3,782.7	3,668	Bearish

The best performer in the index today was Sun Pharmaceutical Industries, up 1.33%. The worst performer was JB Chemicals & Pharmaceuticals, down 3.87%. Looking across the full list, the pressure was spread across both larger and mid-sized pharma names. That confirms that today’s weakness was not isolated.

Top Gainers in Nifty Pharma Today

Company	Price Change	% Change	Session View
Sun Pharmaceutical Industries Ltd.	24.9	1.33%	Strong positive support for the index
Ipca Laboratories Ltd.	21.6	1.15%	Helped offset broader sector weakness
Torrent Pharmaceuticals Ltd.	42	0.84%	Steady intraday strength
Mankind Pharma Ltd.	14	0.59%	Selective buying interest visible

These four stocks were the only gainers in the index and therefore the clear positive contributors to Nifty Pharma today. Among them, Sun Pharma stands out not just because it posted the highest percentage gain, but also because it is listed among the sector’s heavyweight and most active names. When a major stock rises on a day when breadth is weak, its role in holding up the index becomes even more important.

Ipca Laboratories also showed resilience, moving from an opening level of 1,882.1 to close at 1,903.7 after hitting an intraday high of 1,937.9. Torrent Pharmaceuticals and Mankind Pharma added further support, showing that selective strength still existed inside the sector despite the overall negative breadth.

Top Losers in Nifty Pharma Today

Company	Price Change	% Change	Session View
JB Chemicals & Pharmaceuticals Ltd.	-97.1	-3.87%	Sharpest drag among constituents
Glenmark Pharmaceuticals Ltd.	-58.5	-2.54%	Notable pressure through the session
Alkem Laboratories Ltd.	-92.5	-1.69%	Extended weakness from open to close
Natco Pharma Ltd.	-11.5	-1.28%	Closed near the lower end of the session
Aurobindo Pharma Ltd.	-20.5	-1.25%	Weak intraday structure

JB Chemicals & Pharmaceuticals was the biggest loser in the sector, sliding 3.87% from 2,506 to 2,408.9. The stock also touched 2,380 during the day, showing meaningful selling pressure. Glenmark Pharmaceuticals and Alkem Laboratories followed with steeper-than-sector-average declines.

Importantly, the list of drags was not limited to one theme or one size bucket. Along with the major losers above, other names such as Granules India, Biocon, Zydus Lifesciences, Dr. Reddy’s Laboratories, Laurus Labs, Cipla, and Divi’s Laboratories also closed lower. That broad participation on the downside is exactly why the market breadth remains the most important read-through from today’s session.

Heavyweight Stocks and Their Role in Today’s Move

Heavyweight stocks often shape how a sector index behaves. In Nifty Pharma today, the heavyweight basket showed a mixed performance. Sun Pharmaceutical Industries Ltd. rose 1.33%, Torrent Pharmaceuticals Ltd. gained 0.84%, and Mankind Pharma Ltd. added 0.59%. Those gains helped support the benchmark.

However, that support was countered by declines in other large and closely watched names. Divi's Laboratories Ltd. fell 0.33%, Cipla Ltd. lost 0.64%, Dr. Reddy's Laboratories Ltd. dropped 0.75%, Zydus Lifesciences Ltd. declined 0.99%, and Aurobindo Pharma Ltd. fell 1.25%.

This mixed heavyweight setup explains why the index decline remained small even though most stocks were weak. In effect, leadership pockets prevented a larger headline loss, but they were not strong enough to turn the entire sector positive.

Most Active Pharma Stocks to Watch

The most active and closely watched names in the verified dataset include Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla, Dr. Reddy’s Laboratories, Mankind Pharma, Zydus Lifesciences, Lupin, Abbott India, and Aurobindo Pharma. These stocks matter because they often carry higher market attention and can influence sentiment across the broader pharma segment.

Among these active names, Sun Pharma and Torrent Pharmaceuticals stood out positively, while Divi’s Laboratories, Cipla, Dr. Reddy’s Laboratories, Zydus Lifesciences, Lupin, Abbott India, and Aurobindo Pharma ended in the red. That mixed but slightly negative profile in active names aligns with the broader conclusion from the breadth data: the sector had selective strength, but not enough to overcome widespread weakness.

Price Structure and Technical Reading Based on Available Data

Using the available verified session data, Nifty Pharma’s near-term price structure can be described as sideways to bearish. The index opened at 26,337.9, traded up to 26,434.35, slipped to 26,205.4, and finally closed at 26,313.8. Since the close was below both the open and the previous close, the day ended with a mildly negative bias.

The intraday range was 228.95 points, calculated from the day high and day low. The index did attempt an early push higher, but it could not sustain momentum near the top of the range. That inability to hold stronger levels, combined with weak breadth, makes the session more defensive than constructive.

Because only verified price and breadth figures are being used here, the technical view remains intentionally grounded. The main observation is that buyers were present, but not dominant. The market absorbed some of the broader selling through gains in select leaders, yet the underlying tone remained soft. For the next session, traders will likely watch whether the sector can improve breadth and hold above the lower part of today’s range.

Historical Context From the Available Session Data

Compared with the previous close of 26,361.9, Nifty Pharma today ended lower by 48.1 points. That confirms a single-day negative move, though not a deep correction at the index level. The more useful historical insight from today’s dataset is internal, not long term: the market showed divergence between index stability and constituent weakness.

Such sessions are often more informative than they first appear. When an index falls only 0.18% but 80% of its stocks decline, investors should focus less on the small benchmark move and more on the quality of participation. In sector analysis, participation often matters as much as performance. Healthy rallies usually bring broader buying, while fragile sessions tend to depend on a smaller group of leaders.

What Investors Should Watch Next in Nifty Pharma

After today’s close, the first thing investors should track is whether market breadth improves. If the number of advancing pharma stocks rises meaningfully in the next session, today’s weakness may look more like a temporary soft patch inside a still-selective sector. If breadth remains weak again, then the small index decline seen today could begin to matter more.

The second key monitor is leadership. Sun Pharma, Ipca Laboratories, Torrent Pharmaceuticals, and Mankind Pharma were the only gainers today. If these names continue to attract buying while more constituents stabilize, the sector can regain balance. But if the leaders also start losing momentum while the weaker stocks remain under pressure, the broader tone may deteriorate.

Third, investors should watch whether steep losers such as JB Chemicals & Pharmaceuticals, Glenmark Pharmaceuticals, and Alkem Laboratories see follow-through selling or bargain support. Sharp one-day declines in sector constituents can either deepen into a trend or reverse quickly. The next session’s behavior around these names can offer useful clues about sentiment inside the pharma space.

Key Takeaways

Nifty Pharma closed at 26,313.8, down 48.1 points or 0.18%.
The session looked mild at the index level, but internal breadth was weak.
Only 4 stocks advanced, while 16 declined.
Sun Pharmaceutical Industries was the top gainer, up 1.33%.
JB Chemicals & Pharmaceuticals was the top loser, down 3.87%.
Heavyweight support from Sun Pharma and Torrent Pharmaceuticals helped limit the index decline.
The day’s structure points to a sideways to bearish short-term tone based on available price data.
For the next session, breadth and follow-through in both leaders and laggards will be critical.

Published on 19 August 2026 at 4:07 PM IST

Frequently Asked Questions

1. What is Nifty Pharma today?

Nifty Pharma today closed at 26,313.8, down 48.1 points or 0.18% from the previous close.

2. Why did Nifty Pharma fall today?

Nifty Pharma fell mainly because 16 of its 20 constituents closed in the red, showing broad-based weakness despite gains in a few leading stocks.

3. What was the opening value of Nifty Pharma today?

Nifty Pharma opened at 26,337.9.

4. What was the day high and day low of Nifty Pharma?

The index touched a high of 26,434.35 and a low of 26,205.4 during the session.

5. Which stock gained the most in Nifty Pharma today?

Sun Pharmaceutical Industries Ltd. was the top gainer, rising 1.33% to close at 1,900.

6. Which stock fell the most in Nifty Pharma today?

JB Chemicals & Pharmaceuticals Ltd. was the worst performer, falling 3.87% to 2,408.9.

7. How many Nifty Pharma stocks advanced today?

Four stocks advanced in Nifty Pharma today.

8. How many Nifty Pharma stocks declined today?

Sixteen stocks declined in the index today.

9. What is the advance-decline ratio for Nifty Pharma today?

The advance-decline ratio stood at 0.25, meaning there was one advancing stock for every four declining stocks.

10. Which stocks supported Nifty Pharma today?

Sun Pharmaceutical Industries, Ipca Laboratories, Torrent Pharmaceuticals, and Mankind Pharma were the only stocks that closed higher and supported the index.

11. What does today’s market breadth indicate for Nifty Pharma?

Today’s breadth indicates weak internal participation. Even though the index fell only 0.18%, 80% of constituents closed lower.

12. What is the short-term view on Nifty Pharma based on today’s data?

Based on today’s open, close, intraday range, and breadth, the short-term view is sideways to bearish unless participation improves.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.